E-cadherin expression in skin tumors using an AMeX immunohistostaining method.
The AMeX (acetone-methylbenzoate-xylene) method results in good preservation of tissue and morphological details, almost equivalent to that of routinely processed formalin-fixed and paraffin-embedded tissue specimens, and of antigenicity equivalent to that of fresh frozen tissue specimens. It has been reported that the expression of the cell-cell adhesion molecule E-cadherin is often decreased in some types of carcinomas. A decrease in E-cadherin expression is associated with the invasive or metastatic potential of tumor cells. We immunohistochemically examined the expression of E-cadherin with anti-E-cadherin monoclonal antibody in various skin tumors (25 basal cell carcinomas, 11 squamous cell carcinomas, 9 keratoacanthomas, and 11 Bowen's disease) using the AMeX method and found that this method preserved antigenicity well without pretreatment. E-cadherin expression was decreased in 18.2% of squamous cell carcinomas and 33.3% of keratoacanthomas. On the other hand, it was preserved in almost all Bowen's disease and basal cell carcinomas. From the results of our study, we suggest that Bowen's disease and basal cell carcinoma do not have much metastatic potential due to retention of high levels of E-cadherin expression. We hope to apply the AMeX method to other immunohistochemical examinations because this is a very useful staining method.
Koseki
S
S
Department of Dermatology, Yamagata University School of Medicine, Japan.
Ansai
S
S
Aoki
T
T
Hozumi
Y
Y
Mitsuhashi
Y
Y
Kondo
S
S
D000096:Acetone; D000911:Antibodies, Monoclonal; D001565:Benzoates; D001913:Bowen's Disease / Q000378:metabolism / Q000473:pathology; D015820:Cadherins / Q000378:metabolism*; D002280:Basal Cell Carcinoma / Q000378:metabolism / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D007636:Keratoacanthoma / Q000378:metabolism / Q000473:pathology; D012867:Skin / Q000378:metabolism* / Q000473:pathology; D012878:Skin Neoplasms / Q000378:metabolism* / Q000473:pathology; D013048:Specimen Handling / Q000379:methods; D013194:Staining and Labeling / Q000379:methods; D014992:Xylenes
D000911:Antibodies, Monoclonal; D001565:Benzoates; D015820:Cadherins; D014992:Xylenes; D000096:Acetone